Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL):An International DLBCL Rituxan-CHOP Consortium Program Study

Autor: Young, Ken H, Patten, Nancy, Truong, Sim, Eickhoff, Jens, Rocque, Gabrielle L., Malik, Jeffrey T., Li, Yan, Kanehira, Kazunori, Twohig, Matthew, Rehrauer, William M., Waknitz, Michelle A., Kahl, Brad S., Møller, Michael Boe, Tzankov, Alexander, Moreno, Santiago M., Piris, Miguel A., Visco, Carlo, Dybkær, Karen, Chiu, April, Orazi, Attilio, Chang, Jeff C., Bhagat, Govind, Winter, Jane N., Wang, Huan-You, Dunphy, Cherie, O'Neill, Stacey, Hsi, Eric D., Zhao, Xianfeng, Hunt, Kristin, Chen, Weina, Go, Ronald S., Choi, William W.L., Zhou, Fan, Czader, Magdalena, Li, Yong, Selvaggi, Suzanne, Malter, James S., Wu, Lin

Publikováno v: Young, K H, Patten, N, Truong, S, Eickhoff, J, Rocque, G L, Malik, J T, Li, Y, Kanehira, K, Twohig, M, Rehrauer, W M, Waknitz, M A, Kahl, B S, Møller, M B, Tzankov, A, Moreno, S M, Piris, M A, Visco, C, Dybkær, K, Chiu, A, Orazi, A, Chang, J C, Bhagat, G, Winter, J N, Wang, H-Y, Dunphy, C, O'Neill, S, Hsi, E D, Zhao, X, Hunt, K, Chen, W, Go, R S, Choi, W W L, Zhou, F, Czader, M, Li, Y, Selvaggi, S, Malter, J S & Wu, L 2009, ' Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL) : An International DLBCL Rituxan-CHOP Consortium Program Study ', Blood, no. 22, pp. 967 .

Mutations of the TP53 tumor suppressor gene are associated with a poor clinical outcome in DLBCL patients treated with CHOP. The impact of TP53 mutations on clinical outcome of DLBCL patients treated with Rituxan-CHOP has not been comprehensively ana

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::2d92306b68d6b8bbfb8e23b763330b01
https://pure.au.dk/portal/da/publications/clinical-impact-of-tp53-gene-mutations-in-diffuse-large-bcell-lymphoma-dlbcl(62d9ba10-16fc-11df-b95d-000ea68e967b).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.

Autor: Young, Ken H. ^*, Patten, Nancy ^*, Truong, Sim ^*, Eickhoff, Jens ^*, Rocque, Gabrielle L. ^*, Malik, Jeffrey T. ^*, Li, Yan ^*, Kanehira, Kazunori ^*, Twohig, Matthew ^*, Rehrauer, William M. ^*, Waknitz, Michelle A. ^*, Kahl, Brad S. ^*, Moller, Michael B. ^*, Tzankov, Alexander ^*, Moreno, Santiago M. ^*, Piris, Miguel A. ^*, Visco, Carlo ^*, Dybkaer, Karen ^*, Chiu, April ^*, Orazi, Attilio ^*, Chang, Jeff C., Bhagat, Govind ^*, Winter, Jane N., Wang, Huan-You ^*, Dunphy, Cherie ^*, O'Neill, Stacey ^*, Hsi, Eric D., Zhao, Xianfeng, Hunt, Kristin ^*, Chen, Weina ^*, Go, Ronald S., Choi, William W.L. ^*, Zhou, Fan, Czader, Magdalena, Li, Yong ^*, Selvaggi, Suzanne ^*, Malter, James S. ^*, Wu, Lin ^*

Publikováno v: In Blood 20 November 2009 114(22):967-967